Themen aus
Forschung und Bildung
verdienen
Aufmerksamkeit.

Wir schaffen sie.

 
Aktuelles aus Facebook Facebook
Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

CANCER: NEW INHIBITOR EFFECTIVE WHERE OTHER TREATMENTS FAIL

Investigation of targeted treatment in refractory myeloma patients: scientists from Karl Landsteiner University of Health Sciences part of team behind international study.

More: www.pharmiweb.com/press-release/2019-12-03/cancer-new-inhibitor-effective-where-others-fail
... See MoreSee Less

CANCER: NEW INHIBITOR EFFECTIVE WHERE OTHER TREATMENTS FAIL

Investigation of targeted treatment in refractory myeloma patients: scientists from Karl Landsteiner University of Health Sciences part of team behind international study.

More: https://www.pharmiweb.com/press-release/2019-12-03/cancer-new-inhibitor-effective-where-others-fail
Load more
Aktuelle Veranstaltungen

AM PULS Nr. 68

Ökologischer Fußabdruck

Bekannte und unbekannte Größen

 

ap-schriftzug

Montag, 17. 02. 2020  • 18.00 Uhr